drugset / Trial / NCT01050374
Safety and Efficacy of Drug Combinations Against Schistosomiasis
RandomizedParallel-groupDouble-blindTreatment
Summary
This randomised, controlled, double-blinded clinical study investigates the safety and efficacy of MBD in combination with PZQ in the treatment of SCH and STH in children aged 1-15 years of age.
Timeline
- Start
- 2007-10
- Primary completion
- 2008-10
- Completion
- 2008-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Albendazole | Small molecule | 400 mg | — |
| Comparator | Mebendazole | Small molecule | 500 mg | — |
| Comparator | Praziquantel | Small molecule | 40 mg/kg | — |